International consortium publishes recommendations for neoadjuvant melanoma trials
An international consortium, led in part by clinicians and researchers from Â鶹ӳ» MD Anderson Cancer Center, has published a series of best-practice recommendations for conducting clinical trials for neoadjuvant, or pre-surgical, therapies in patients with locally advanced melanoma.
The report, published in Lancet Oncology, provides recommendations for clinical trial design, including patient inclusion criteria...
Study shows early-onset colorectal cancers have distinct features
Through in-depth retrospective analysis of data from more than 36,000 patients, a new study led by researchers at Â鶹ӳ»...
Pancreatic Cancer Moon Shot sharpens pre-surgical treatment
Neoadjuvant therapy is treatment, such as chemotherapy or radiation, given before a patient has surgery. This approach is used in many cancer...
The search for valuable cancer-related proteins
MD Anderson’s proteomics platform provides a valuable institutional resource, complete with state-of-the-art instruments and specialized expertise to help researchers analyze and understand thousands of cancer-related proteins. These proteins may be useful as therapeutic targets, early detection signals or biomarkers of cancer treatment response for a number of disease types, including lung, colon, breast, ovarian, pancreatic, prostate...
Treatment advances for CLL, the most common leukemia
Chronic lymphocytic leukemia (CLL), which originates in white blood cells known as lymphocytes, is the most common form of leukemia in adults...
$5.1 million grant to expand cervical cancer diagnosis and prevention in Mozambique
MD Anderson Cancer Center researchers, together with collaborators from Mozambique, Brazil and the U.S., have been awarded a $5.1 million...
Expressive writing improves quality of life for breast cancer survivors
Receiving a cancer diagnosis is a life-changing event, and the path through treatment can be among the hardest things a person goes through...